These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9125193)

  • 21. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease.
    Donahue JE; Flaherty SL; Johanson CE; Duncan JA; Silverberg GD; Miller MC; Tavares R; Yang W; Wu Q; Sabo E; Hovanesian V; Stopa EG
    Acta Neuropathol; 2006 Oct; 112(4):405-15. PubMed ID: 16865397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Astroglial expression of ceramide in Alzheimer's disease brains: a role during neuronal apoptosis.
    Satoi H; Tomimoto H; Ohtani R; Kitano T; Kondo T; Watanabe M; Oka N; Akiguchi I; Furuya S; Hirabayashi Y; Okazaki T
    Neuroscience; 2005; 130(3):657-66. PubMed ID: 15590150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoradiographic distribution of M1, M2, M3, and M4 muscarinic receptor subtypes in Alzheimer's disease.
    Rodríguez-Puertas R; Pascual J; Vilaró T; Pazos A
    Synapse; 1997 Aug; 26(4):341-50. PubMed ID: 9215593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a mutant-like conformation of p53 in fibroblasts from sporadic Alzheimer's disease patients.
    Uberti D; Lanni C; Carsana T; Francisconi S; Missale C; Racchi M; Govoni S; Memo M
    Neurobiol Aging; 2006 Sep; 27(9):1193-201. PubMed ID: 16165254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease.
    de la Monte SM; Sohn YK; Wands JR
    J Neurol Sci; 1997 Nov; 152(1):73-83. PubMed ID: 9395128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of oxidative and nitrosative stress in brain on p53 proapoptotic protein in amnestic mild cognitive impairment and Alzheimer disease.
    Cenini G; Sultana R; Memo M; Butterfield DA
    Free Radic Biol Med; 2008 Jul; 45(1):81-5. PubMed ID: 18439434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of acupuncture on the p53 protein expression of mice with Alzheimer's disease].
    Liu JF; Zhang Y; Sun JP; Xu SS; Zhang XZ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Oct; 33(10):1367-71. PubMed ID: 24432681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glutathionylation of the pro-apoptotic protein p53 in Alzheimer's disease brain: implications for AD pathogenesis.
    Di Domenico F; Cenini G; Sultana R; Perluigi M; Uberti D; Memo M; Butterfield DA
    Neurochem Res; 2009 Apr; 34(4):727-33. PubMed ID: 19199029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-genomic rewiring of vitamin D receptor to p53 as a key to Alzheimer's disease.
    Lai RH; Hsu YY; Shie FS; Huang CC; Chen MH; Juang JL
    Aging Cell; 2021 Dec; 20(12):e13509. PubMed ID: 34725922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRCA1 and p53 tumor suppressor molecules in Alzheimer's disease.
    Nakanishi A; Minami A; Kitagishi Y; Ogura Y; Matsuda S
    Int J Mol Sci; 2015 Jan; 16(2):2879-92. PubMed ID: 25636033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of association between clinical symptoms and postmortem indices of brain serotonin function in Alzheimer's disease.
    Lawlor BA; Ryan TM; Bierer LM; Schmeidler J; Haroutunian V; Mohs R; Davis KL
    Biol Psychiatry; 1995 Jun; 37(12):895-6. PubMed ID: 7548465
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacogenetics and pharmagenomics, trends in normal and pathological aging studies: focus on p53.
    Lanni C; Racchi M; Uberti D; Mazzini G; Stanga S; Sinforiani E; Memo M; Govoni S
    Curr Pharm Des; 2008; 14(26):2665-71. PubMed ID: 18991686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin Resistance in Alzheimer Disease: p53 and MicroRNAs as Important Players.
    Gasiorowski K; Brokos B; Leszek J; Tarasov VV; Ashraf GM; Aliev G
    Curr Top Med Chem; 2017; 17(12):1429-1437. PubMed ID: 28049397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Speciation analysis of trace elements in the brains of individuals with Alzheimer's disease with special emphasis on metallothioneins.
    Richarz AN; Brätter P
    Anal Bioanal Chem; 2002 Feb; 372(3):412-7. PubMed ID: 11939525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxytocin in Alzheimer's disease: postmortem brain levels.
    Mazurek MF; Beal MF; Bird ED; Martin JB
    Neurology; 1987 Jun; 37(6):1001-3. PubMed ID: 3587615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phospholipase pathway in Alzheimer's disease brains: decrease in Galphai in dorsolateral prefrontal cortex.
    Young RA; Talbot K; Gao ZY; Trojanowski JQ; Wolf BA
    Brain Res Mol Brain Res; 1999 Mar; 66(1-2):188-90. PubMed ID: 10095092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53 in neurodegenerative diseases and brain cancers.
    Checler F; Alves da Costa C
    Pharmacol Ther; 2014 Apr; 142(1):99-113. PubMed ID: 24287312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in the regional brain histamine and histidine levels in postmortem brains of Alzheimer patients.
    Mazurkiewicz-Kwilecki IM; Nsonwah S
    Can J Physiol Pharmacol; 1989 Jan; 67(1):75-8. PubMed ID: 2713757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alzheimer's response.
    Landsberg JP; McDonald B; Watt F
    Nature; 1993 Jul; 364(6435):294. PubMed ID: 8332186
    [No Abstract]   [Full Text] [Related]  

  • 40. Alterations of low molecular weight acid phosphatase protein level in Alzheimer's disease.
    Shimohama S; Fujimoto S; Chachin M; Taniguchi T; Perry G; Whitehouse PJ; Kimura J
    Brain Res; 1995 Nov; 699(1):125-9. PubMed ID: 8616601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.